Skip to main content
Bronwen Shaw, MD, Hematology, Milwaukee, WI, Froedtert and the Medical College of Wisconsin Froedtert Hospital

BronwenEShawMD

Hematology Milwaukee, WI

Physician

Dr. Shaw is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Shaw's full profile

Already have an account?

Education & Training

  • University of Cape Town Faculty of Medicine
    University of Cape Town Faculty of MedicineClass of 1993

Certifications & Licensure

  • WI State Medical License
    WI State Medical License 2015 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Current Use of Biosimilar G-CSF for Haematopoietic Stem Cell Mobilisation  
    Bronwen Shaw, MD, Nature
  • Related Peripheral Blood Stem Cell Donors Experience More Severe Symptoms and Less Complete Recovery at 1-Year Compared to Unrelated Donors  
    Parameswaran N Hari, David A Jacobsohn, Joseph P McGuirk, Mary M Horowitz, Walter Longo, Thomas Spitzer, Daniel J Weisdorf, Shahram Mori, David C Delgado, Marcie L Ric..., Haematologica
  • Motives for Joining an Unrelated HSC Donor Registry: Description, Categorization, and Association with Donor Availability  
    Bronwen Shaw, MD, Nature
  • Join now to see all

Abstracts/Posters

  • Patient-Reported Neuropsychiatric Outcomes of Long-Term Survivors after Chimeric Antigen Receptor (CAR)-T Cell Therapy
    Bronwen E. Shaw, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Building a National CML Registry
    Bronwen E. Shaw, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Excellent Overall Survival and Low Incidence of Late Effects in Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Sickle Cell Disease: A Report from the...
    Bronwen E. Shaw, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Impact of Myeloablative Total Body Irradiation Versus Chemotherapy on Late Effects and Survival Among Adolescent and Young Adult Survivors of Hematopoietic Cell Transp... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Risk Factors for the Development of Cutaneous Melanoma after Allogeneic Hematopoietic Cell Transplantation 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Weighty Choices: Selecting Optimal G-CSF Doses for Stem Cell Mobilization to Optimize Yield 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Patient-Reported Outcomes and Overall Survival After Allogeneic Hematopoietic Stem Cell Transplantation
    Patient-Reported Outcomes and Overall Survival After Allogeneic Hematopoietic Stem Cell TransplantationJune 22nd, 2022
  • Center for International Blood & Marrow Transplant Research Celebrates 50 Years
    Center for International Blood & Marrow Transplant Research Celebrates 50 YearsApril 22nd, 2022
  • Post-HCT Cyclophosphamide Boosts Transplant Success
    Post-HCT Cyclophosphamide Boosts Transplant SuccessMay 7th, 2021
  • Join now to see all

Hospital Affiliations